Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients
Association Between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients With Tamoxifen Treatment
Sponsor: Inje University
Listed as NCT01169792, this observational or N/A phase trial focuses on Antineoplastic Agents and Breast Neoplasms and remains completed. Sponsored by Inje University, it has been updated 10 times since 2026, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 5 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
May 2018 — Nov 2020 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Inje University
- Yonsei University
For direct contact, visit the study record on ClinicalTrials.gov .